Assessing the Effectiveness of Patient-Centric Leadership on Overall Quality of Life in Chronic Disease Management
DOI:
https://doi.org/10.56294/hl2022150Keywords:
Effectiveness, Management, Empowerment, Involvement, Leadership, TrainingAbstract
Introduction: (This study aimed to evaluate the effectiveness of patient-oriented leadership on the improvement of quality of life (QoL) in patients with chronic diseases. The authors introduced the need for patient-centered care as the prevalence of chronic diseases has reached alarming proportions, both for the patient and the health system. They emphasized the importance of patient-oriented leadership in fostering patient empowerment, engagement in decision-making, and better health results.
Methods: It was not necessary to change task 1 methods as it was a basic task that was used to introduce a customized quantitative questionnaire with pre-test and post_test on patient quality of life to measure the effectiveness of patient-centric leadership on overall quality of life. A total of 200 patients with chronic diseases who were undergoing treatment were divided into an intervention group that received patient-centered leadership training and a control group that received conventional care. The validated scales used in the questionnaire encompassed patient empowerment, involvement in decision-making, and overall quality of life.
Results: Very briefly, the data demonstrated a substantial improvement in the proportion of empowered patients, involvement with making decisions, and quality of life in the intervention group relative to the control group. They also observed a positive association between patient-centric leadership and patient empowerment and engagement in decision-making. Patient-centred leadership significantly impacts the improvement of the quality of life of patients with chronic diseases.
Conclusions:Thus, the study demonstrated that it is the consolidated, systematic training in patient-centered leadership that promotes patient empowerment and engagement in their own disease decisions, which is translated into a life in which, through patient potential, the quality of life increases through patient-centered leadership. This result underscores the need for patients' descriptors in healthcare leadership based care, and the value of adopting this patient-centered approach in the management of chronic disease. Long-term implications of patient-centric leadership on health outcomes in chronic disease management should be further established.
References
[1] Aye, Y. M., Liew, S., Neo, S. X., Li, W., Ng, H. L., Chua, S. T., ... & Xu, Z. (2020). Patient-centric care for Parkinson's disease: From hospital to the community. Frontiers in neurology, 11, 502.
[2] Haughney, J., Winders, T. A., Holmes, S., Chanez, P., Saul, H., & Menzies-Gow, A. (2020). Global quality standard for identification and management of severe asthma. Advances in therapy, 37, 3645-3659.
[3] Dockendorf, M. F., Hansen, B. J., Bateman, K. P., Moyer, M., Shah, J. K., & Shipley, L. A. (2021). Digitally enabled, patient‐centric clinical trials: shifting the drug development paradigm. Clinical and Translational Science, 14(2), 445-459.
[4] Jackson, Y., Janssen, E., Fischer, R., Beaverson, K., Loftus, J., Betteridge, K., ... & Lundie, M. (2019). The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management. Expert Review of Pharmacoeconomics & Outcomes Research, 19(4), 383-396.
[5] Kaur, H. (2021). Digitally Enabled, Wearable Remote Patient Monitoring of Clinical Trials to Assess Patient Reported Outcomes-A Systematic Review: Shifting Paradigm from Site-Centric to Patient Centric Health Care.
[6] Church, D. L., & Naugler, C. (2020). Essential role of laboratory physicians in transformation of laboratory practice and management to a value-based patient-centric model. Critical Reviews in Clinical Laboratory Sciences, 57(5), 323-344.
[7] Howell, E., Pena, I., Kantsiper, M., Dy, S., Abebe, E., Hannum, S., ... & Brown, R. Project Title: Patient-Centric Risk Model for Medication Safety During Care Transitions.
[8] Wilson, H., Dashiell-Aje, E., Anatchkova, M., Coyne, K., Hareendran, A., Leidy, N. K., ... & Wyrwich, K. (2018). Beyond study participants: a framework for engaging patients in the selection or development of clinical outcome assessments for evaluating the benefits of treatment in medical product development. Quality of Life Research, 27, 5-16.
[9] Hartog, N. L., Williams, K. W., & Abraham, R. S. (2019). “The state of the union”: current and future perspectives on patient-centric care for primary immunodeficiencies and immune deregulatory diseases. Frontiers in immunology, 10, 1783.
[10] Ruesch, M. N., Benetti, L., Berkay, E., Cirelli, D. J., Frantz, N., Gastens, M. H., ... & Stults, J. (2021). Strategies for setting patient-centric commercial specifications for biotherapeutic products. Journal of Pharmaceutical Sciences, 110(2), 771-784.
Published
Issue
Section
License
Copyright (c) 2022 Udaybhanu Rout , Ram Garg , Renuka Jyothi.S , A Geetha Bhavani (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
